Breaking news

The AI Dilemma: Balancing Revolutionary Promise With Existential Uncertainty

The AI Journey: New Parent, New Challenges, New Questions

Daniel Roher began working on a documentary about artificial intelligence while preparing for the birth of his first child. The project reflects broader questions about how AI may shape society and everyday life. His film, The AI Doc: Or How I Became an Apocaloptimist, opened its theatrical run on March 27.

Behind The Scenes: Capturing The Pulse Of A Tech Revolution

Diane Becker and Ted Tremper, producers of the film, discussed the production process during an address to CNBC’s Technology Executive Council. Tremper said he spent significant time reviewing podcasts and industry discussions to better understand the subject. He contacted a wide range of AI experts, sending around 90 outreach emails and receiving six responses.

The film features 40 on-camera interviews with technology leaders, including Sam Altman, CEO of OpenAI; Dario Amodei, CEO of Anthropic; and Demis Hassabis, CEO of Google DeepMind. Some high-profile figures, including Mark Zuckerberg and Elon Musk, declined to participate.

Challenging The Binary: From Utopia To Apocalypse

The documentary examines how artificial intelligence is often framed in opposing terms, from potential breakthroughs to significant risks. Roher asks participants to explain AI in simple language, highlighting the difficulty of translating complex technical concepts into accessible explanations. This approach also reflects the gap between rapid technological development and broader public understanding. Tremper said discussions around AI often shift between optimism and concern, which shaped the structure of the film.

An Invitation To Join The Conversation

The film received early attention through screenings at the Sundance Film Festival and international events, including in Copenhagen. Becker said public discussion around AI has broadened beyond earlier perceptions of it as a niche topic. She noted that conversations now include a wider range of perspectives on how AI may affect different parts of society.

Both producers said their understanding of AI changed during production. They also emphasized the role of users in engaging critically with tools such as ChatGPT and Claude, particularly as these systems become more widely adopted.

EU Records €220.5 Billion Pharmaceutical Trade Surplus In 2025

The European Union secured a historic trade surplus in medicinal and pharmaceutical products in 2025, according to a report from Eurostat. Export figures reached €366.2 billion while imports totaled €145.7 billion, leading to a surplus of €220.5 billion.

Robust Growth In Exports And Imports

Exports increased by 16.0% from €315.7 billion in 2024. Imports rose by 21.0% from €120.4 billion over the same period. The data show continued expansion in trade volumes across the sector.

Leading National Performances

Ireland recorded the highest exports to non-EU countries at €93.8 billion. Germany and Belgium followed with €67.9 billion and €38.5 billion, respectively. Italy led imports at €27.5 billion, with Belgium and Germany also recording significant volumes.

Global Trade Partnerships

The United States was the largest destination for EU exports, accounting for 43.8% or €160.6 billion. Switzerland followed with 16.3% (€59.7 billion), while the United Kingdom accounted for 5.6% (€20.6 billion). On the import side, the United States supplied 41.2% of total imports (€60.1 billion), followed by Switzerland at 28.4% (€41.4 billion) and China at 9.0% (€13.1 billion).

The Future Forbes Realty Global Properties
eCredo
Uol
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter